Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Donepezil Hydrochloride Tablets, 23 mg
7/29/2013 10:16:08 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced yesterday that it has launched Donepezil Hydrochloride Tablets, 23 mg, a therapeutic equivalent generic version of ARICEPT®, 23 mg in the U.S. market on July 26, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Donepezil Hydrochloride Tablets, 23 mg. The ARICEPT®, 23 mg brand had U.S. sales of approximately $92.6 Million MAT for the most recent twelve months ending in May 2013 according to IMS Health*. Dr. Reddy’s Donepezil Hydrochloride Tablets, 23 mg is available in bottle count sizes of 30 and 90.
Help employers find you! Check out all the jobs and post your resume.
comments powered by